Pancreatic Cancer Research

ResearcherQueen Mary University of LondonActive in the last 2 years

Gunnel Halldén

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5680-2895; OpenAlex author ID A5089200111. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 8

  1. Inhibition of Bromodomain Proteins Enhances Oncolytic HAdVC5 Replication and Efficacy in Pancreatic Ductal Adenocarcinoma (PDAC) Models. Last author DOI 10.3390/ijms25021265↗
  2. Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Mod… Last author DOI 10.3390/ijms23168884↗
  3. Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer. Last author DOI 10.1038/s41598-019-49150-9↗
  4. Advances in oncolytic adenovirus therapy for pancreatic cancer. First author DOI 10.1016/j.canlet.2018.07.006↗
  5. The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells. Last author DOI 10.1158/1535-7163.mct-17-0671↗
  6. The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11. Last author DOI 10.18632/oncotarget.7310↗
  7. An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or g… Last author DOI 10.1038/cgt.2011.45↗
  8. The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models. Last author DOI 10.1038/gt.2011.141↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tizong Miao · 1 shared paper, 2024 · strength 0.22
  2. Yaohe Wang · 1 shared paper, 2024 · strength 0.22
  3. Y. K. Stella Man · 2 shared papers, 2018–2019 · strength 0.19
  4. Alan L. Parker · 2 shared papers, 2018–2019 · strength 0.19
  5. Yang Kee Stella Man · 1 shared paper, 2022 · strength 0.19
  6. Callum Baird Nattress · 1 shared paper, 2018 · strength 0.17
  7. Constantia Pantelidou · 2 shared papers, 2016–2018 · strength 0.17
  8. Gioia Cherubini · 2 shared papers, 2011–2016 · strength 0.11
  9. Elisabete Carapuça · 1 shared paper, 2019 · strength 0.11
  10. John F. Marshall · 1 shared paper, 2018 · strength 0.09
  11. Madhumita Bhattacharyya · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.